H ip involvement is a common extraspinal arthritic manifestation in patients with ankylosing spondylitis (AS) (1) . In North Africa, AS occurs in 40% of patients after 10-year of disease duration (1) . Hip replacement surgery in patient with end-stage hip disease remains the standard operation. Hip prosthesis has however a limited life span and is not devoid from complications (2) . Little data are available on the effectiveness of conservative treatment strategies. TNF inhibitors have been proven effective on AS activity parameters. Their structural effect especially on hip disease is however little studied (2). We describe four new cases of reparative changes of a damaged hip joint after treatment with TNF inhibitors. Radiological hip progression was assessed using BASRI-h (bath ankylosing spondylitis radiographic index of the hip) and the average of hip joint space measured at three distinct sites according to Konsta et al. (3) .
Case Presentation
There were 3 men and 1 woman. Hip involvement was bilateral in all cases. Etanercept was prescribed in 3 cases and infliximab in 1 case. Demographic, clinical, radiological and biologic data at baseline are presented in table 1. At baseline, all patients had a painful and limited hips with high disease activity (mean BASDAI (bath ankylosing spondylitis activity index) 4.7) (4-6), and an important functional impairment with a mean BASFI (bath ankylosing spondylitis functional index) at 6.6 (3.7-9), and a mean index of severity for osteoarthritis for the hip (ISH).at 15.6 (11-20) (ISH index entails three main items which more or less include subjective issues like: pain or discomfort, maximum distance walking; and activities of daily living). Our data, as well as those of literature, suggest that the positive effect of TNF inhibitors observed on structural changes in patients with rheumatoid arthritis (RA) is also seen on osteodestructive changes in patients with AS. In fact, unlike the classical structural changes of AS in the spine, inflammation of the subchondral bone marrow in the hip (8) , leads to an erosive disease with joint space narrowing which causes joint destruction. Olthough, there is not a new bone formation. A similar case of hip radiographic repair after a year of infliximab treatment in a patient suffering from SA has been reported in the literature (9) .
Radiographic repair of the hip in isolated RA cases have also been reported (10-13) including four patients with juvenile-onset RA. The mechanisms of improved hip joint space have not been studied. Nonetheless, it has a case reported by Sakuma et al (13) where it was investigated if hip radiographic repair reflected a true histopathological repair on the femoral head. This was a juvenile-onset RA patient with radiographic improvement in the hip under TNF inhibitor. This study showed an eburnated femoral surface and partially coated by fibrous tissue. This tissue was identified microscopically as fibrocartilage. These findings suggest that the x-ray repair could be due to the presence of fibrous cartilage overlying a partially repaired joint
In conclusion, TNF inhibitors seem to be effective on hip joint disease in patients with AS. Further studies are however required to confirm and evaluate their effect on preventing hip impairment.
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